| 1 |
28220640 | Multidimensional contractile reserve predicts adverse outcome in patients with severe systolic heart failure: a 4-year follow-up study. | 2017 Jul |
1 |
| 2 |
22471594 | Effect of lipopolysaccharide, cytokines, and catecholamines on brain natriuretic peptide release from human myocardium. | 2012 Aug |
2 |
| 3 |
21297144 | Preoperative B-type natriuretic peptide, and not the inflammation status, predicts an adverse outcome for patients undergoing heart surgery. | 2011 May |
2 |
| 4 |
20729741 | BNP as marker of heart dysfunction in patients with liver cirrhosis. | 2010 Nov |
1 |
| 5 |
19401301 | Reduced contractile reserve of the systemic right ventricle under Dobutamine stress is associated with increased brain natriuretic peptide levels in patients with complete transposition after atrial repair. | 2009 Jul |
2 |
| 6 |
19539144 | Lowered B-type natriuretic peptide in response to levosimendan or dobutamine treatment is associated with improved survival in patients with severe acutely decompensated heart failure. | 2009 Jun 23 |
1 |
| 7 |
16849043 | Acute changes in N-terminal pro-brain natriuretic peptide induced by dobutamine stress echocardiography. | 2007 Aug |
1 |
| 8 |
17218198 | B-type natriuretic peptide is not a marker of ischemia during dobutamine stress echocardiography. | 2007 Jan |
1 |
| 9 |
16015444 | Relationship of extent and nature of dysfunctional myocardium to brain natriuretic peptide in patients with ischemic left ventricular dysfunction. | 2005 Apr-Jun |
1 |
| 10 |
16112956 | Clinical and laboratory diagnostics of cardiovascular disease: focus on natriuretic peptides and cardiac ischemia. | 2005 |
1 |
| 11 |
15019872 | Usefulness of plasma brain natriuretic peptide levels in predicting dobutamine-induced myocardial ischemia. | 2004 Mar 15 |
3 |
| 12 |
10441688 | Plasma concentrations of atrial and brain natriuretic peptides and cyclic guanosine monophosphate in response to dobutamine infusion in patients with surgically repaired tetralogy of fallot. | 1999 Sep-Oct |
2 |